Diagnostic value of flow mediated dilatation measurement for coronary artery lesions in men under 45 years of age by Kaźmierski, Maciej et al.
ORIGINAL ARTICLE
Cardiology Journal
2010, Vol. 17, No. 3, pp. 288–292
Copyright © 2010 Via Medica
ISSN 1897–5593
288 www.cardiologyjournal.org
Address for correspondence:  Maciej Kaźmierski, MD, 3rd Department of Cardiology, Medical University of Silesia,
Ziołowa 45/47, 40–635 Katowice, Poland, tel./fax: +48 32 252 39 30, e-mail: maciejkazmierski@poczta.onet.pl
Received: 11.09.2009 Accepted: 29.12.2009
Diagnostic value of flow mediated dilatation
measurement for coronary artery lesions in
men under 45 years of age
Maciej Kaźmierski1, Aleksandra Michalewska-Włudarczyk1,
Łukasz J. Krzych2, Michał Tendera1
13rd Department of Cardiology, Medical University of Silesia, Katowice, Poland
21st Department of Cardiac Surgery, Medical University of Silesia, Katowice, Poland
Abstract
Background: In those without symptoms of coronary artery disease (CAD), the incidence of
coronary events is still high. The aim of this study was to evaluate whether flow mediated
dilatation (FMD) is a useful tool in identifying those with CAD in who are under 45 years of age.
Methods and results: Seventy five men below 45 years of age, hospitalized in order to
perform elective coronary angiography, were enrolled into the study. Based on coronary angio-
graphy findings, they were divided into two groups: study group (Group A, n = 55) with
obstructive coronary lesions and the control group (Group B, n = 20) without significant
lesions in coronary arteries. In all subjects atherosclerosis risk factors were analyzed. Endothe-
lial dysfunction was assessed in ultrasound via FMD. FMD was significantly lower in the
study group than in the control group (3.92 ± 1.1 vs 6.51 ± 1.1, p < 0.001). FMD, as well as
age, diabetes and positive family history, appeared to be statistically significant CAD risk
factors. AUROC for FMD was 0.957 (p < 0.001), meaning this model had an almost complete
ability to predict the presence of CAD. AUROC for CAD diagnosis on the basis of significant
clinical parameters was 0.992 (p < 0.001), also representing almost complete ability of this model
to identify asymptomatic subjects with CAD risk.
Conclusions: The evaluation of endothelial function by the use of FMD in the population of
men below 45 years of age with diabetes and positive family history can help in identifying
subjects at high risk of coronary artery disease. (Cardiol J 2010; 17, 3: 288–292)
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Introduction
Among those without coronary artery disease
(CAD) symptoms, the incidence of coronary events
is still high. This concerns also the population with
early onset of CAD, when the symptoms occur be-
fore 45 years of age. According to many epidemio-
logical studies, about 40% of all serious coronary
events occur in 20% of the population, in subjects
with three or more risk factors. This means that
almost 60% of all serious coronary events occur in
the larger population, in which classical atheroscle-
rosis risk factors are less frequent or less intense.
Therefore, in this group risk stratification is re-
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quired to define the risk of a coronary event more
precisely. It has been proved that the risk of a coro-
nary event correlates strongly with the presence
of atherosclerotic lesions [1]. In many studies,
a positive correlation between endothelial dysfunc-
tion and atherosclerotic lesions formation has been
observed [2–4].
The aim of this study was to evaluate whether
flow mediated dilatation (FMD) can be useful in
diagnosing CAD in the population below 45 years
of age.
Methods
Seventy five male patients below 45 years of
age with a positive stress test result, admitted to
our department in order to perform elective coro-
nary angiography, were enrolled into the study.
Based on coronary angiography findings, they were
divided into two groups: the study group (Group A)
with obstructive coronary lesions and the control
group (Group B) without lesions in coronary arteries.
Angiographic criteria: patients with coronary
lesions narrowing vessel lumen £ 10% of vessel
cross-section were considered without lesions and
included in the control group. Patients with coro-
nary lesions narrowing vessel lumen ≥ 50% of ves-
sel cross section were included in the study group.
Patients with coronary lesions narrowing artery lu-
men 10–50% of vessel cross-section were exclud-
ed from the study.
The following atherosclerosis risk factors were
analyzed: hypertension, hypercholesterolemia,
diabetes, smoking, overweight or obesity, family
history of CAD. For the purpose of this study, the
following definitions were used: hypertension —
arterial blood pressure equal to or exceeding 140/
/90 mm Hg and/or use of anti-hypertensive thera-
py; hypercholesterolemia — plasma cholesterol
concentration exceeding 200 mg/dL at the time of
the study or any time in the past; diabetes — diag-
nosis of diabetes during index hospitalization or the
use of anti-diabetic agents and/or diet; obesity —
body mass index (BMI) exceeding 30 kg/m2; smok-
er — smoking at least one cigarette/day for at least
six months; positive family history — myocardial in-
farction in parents or siblings before 55 years of age.
The study was approved by the Bioethics
Committee of the Medical University of Silesia and
all patients provided written informed consent.
Study protocol
All patients used vascular agents, such as ni-
trates, calcium blockers, beta-adrenolytics, ACE-
-inhibitors, and statins which were administered
routinely, also before ultrasound examination and
coronary angiography.
Ultrasound examination of FMD was per-
formed after overnight fast in the morning (before
morning medications — minimum 8–12 hours post
evening medications), after 15 minutes rest in the
horizontal position, by means of SONOS 5000 ul-
trasoud scanner (Hewlett Packard, USA) with the
linear transducer 11 MHz.
The diameter of the right brachial artery was
measured 3–5 cm above the antecubital space in the
M-mode, at baseline. The measurement was per-
formed in the end-diastolic phase, marking the
diameter between anterior and posterior artery wall
in the zone between media and adventitia (‘m-line’).
An average of three measurements was taken and
further analyzed to calculate FMD. Subsequently,
a pneumatic tourniquet was placed on the upper part
of the right forearm and inflated for four minutes to
a pressure of 200 mm Hg or 50 mm Hg above sys-
temic arterial blood pressure. Sixty seconds after
cuff release, the diameter of the right brachial ar-
tery was measured three times. FMD was calcu-
lated as an increase of vascular diameter (in per-
centage) from the difference between maximum and
baseline brachial artery diameter.
After a 15 minute break, a nitroglycerine-me-
diated dilatation test (NTG-MD test) was performed
using 0.4 mg of sublingual nitroglycerine (Nitromint
0.4 mg/dose, Egis Pharmaceuticals, Hungary). Be-
fore nitroglycerine administration, brachial artery
diameter was measured three times as the baseline,
and five  minutes after nitroglycerine administration,
it was measured another three times. NTG-MD was
calculated as an increase of vascular diameter (in
percentage) from the difference between maximum
and baseline brachial artery diameter [5].
Coronary angiography was performed with the
Judkins method from the right femoral artery ac-
cess. After 6 F sheath insertion, angiography of both
coronary arteries was done using contrast agent
Visipaque 320 (Amersham Health, USA), showing
right coronary artery in at least two opposite pro-
jections and left coronary artery in at least four dif-
ferent projections. Coronary artery narrowings
were calculated digitally (QCA, Quantitative Coro-
nary Angiography).
Statistical analysis
Qualitative variables were shown as absolute
values and percentage and quantitative variables as
mean and standard deviation (for normal distribu-
tion) and as median and interquartile range (for dis-
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tribution different from normal). Type of distribu-
tion was assessed using the Shapiro-Wilk test. The
differences between the groups were interpreted
on the basis of Student’s t-test (for normal distri-
bution) and Mann-Whitney U test (for distribution
different from normal), and for qualitative data on
the basis of c2 test or the exact Fisher test. Addi-
tionally, in order to diminish the influence of con-
founding variables, multivariate analysis was per-
formed in the model of logistic forward stepwise
regression, where the dependent variable was an-
giographically verified presence of coronary artery
disease, and the independent variables were age,
BMI, the presence of coexisting diseases, LDL cho-
lesterol and triglycerides concentrations, diabetes,
positive family history and FMD value. The ability
of FMD measurement, and of all clinical parame-
ters together, to diagnose coronary artery disease
was verified on the basis of ROC curve analysis (the
accuracy of patients’  assignment to study/control
group in particular FMD cut-off points). For the
model adjustment assessment, the value of the area
under the ROC (AUROC) was calculated as was its
statistical significance. P value < 0.05 was consi-
dered statistically significant.
Results
Seventy five males were enrolled into the
study, 55 into the study group (Group A) and 20 into
the control group (Group B). Patients in Group A
more frequently had diabetes and were overweight,
and had significantly higher triglyceride concentra-
tion in comparison to the control group. The char-
acteristics of the groups are presented in Table 1.
Patients in the study group had a significantly
lower FMD value compared to the control group
(Table 2).
The analysis of coronary artery disease deter-
minants is shown in Table 3. In this multivariate
model, only the influence of FMD (logOR = 0.94,
95% CI 0.86–0.97), age (logOR = 0.3, 95% CI 0.04–
–0.71), diabetes (logOR = 0.92, 95% CI 0.81–0.98)
and positive family history (logOR = 0.92, 95% CI
0.82–0.98) appeared to be statistically significant.
ROC curve for CAD diagnosis on the basis of
FMD is presented in Figure 1. Each 1% increase in
FMD value diminished the likelihood of CAD diag-
nosis almost nine times (logOR = 0.102, 95% CI
0.024–0.262, p < 0.001). The value of the AUROC
was 0.957 (p < 0.001), which means there was an
almost complete ability of this model to predict the
presence of CAD.
ROC curve for CAD diagnosis on the basis of
clinical parameters in the model of logistic regression
is shown in Figure 2. After adjustment for statistical-
ly significant determinants of CAD prevalence,
Table 3. Determinants of coronary artery disease (CAD) prevalence in multivariate model.
Variable logOR 95% CI
Flow mediated dilatation (%) Step 1 0.94 0.859–0.974
Age (years) Step 2 0.3 0.04–0.71
Diabetes Step 3 0.922 0.807–0.979
Positive family history of CAD Step 4 0.925 0.817–0.98
R2 = 0.655; p < 0.001; logOR — logistic odds ration value; 95% CI — 95% confidence interval of logistic odds ration
Table 2. Flow mediated dilatation (FMD) value.
Variable Group A Group B p
FMD (%) 3.92 ± 1.1 6.51 ± 1.1 < 0.001
Table 1. Characteristics of the groups.
Variables Group A Group B p
Age (years) 38.1 ± 4.3 40.9 ± 4.8 0.006
BMI [kg/m2] 27.7 ± 3.3 27.0 ± 1.9 0.5
Overweight (%) 100.0 83.6 0.05
Smoking (ever) (%) 85.4 100.0 0.07
Diabetes (%) 25.0 7.3 0.05
Arterial 50.9 70.0 0.1
hypertension (%)
Positive family 45.0 30.0 0.2
history of CAD (%)
Total cholesterol 224.6 ± 48.6 216.8 ± 33.7 0.5
[mg/dL]
LDL cholesterol 151.9 ± 43.5 139.8 ± 32.7 0.3
[mg/dL]
Triglycerides 167.8 ± 68.4 131.0 ± 53.5 0.02
[mg/dL]
BMI — body mass index; CAD — coronary artery disease
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AUROC was 0.992 (p < 0.001), which represents
an almost complete ability of this model to identify
subjects at risk of CAD.
Discussion
Endothelium is the largest endocrine gland in
the organism, which maintains circulatory system
homeostasis using many biological transmitters [6].
As a non-invasive ultrasound technique which en-
ables the evaluation of the brachial artery, FMD has
been commonly recognized as a useful index of
endothelial function [5]. The methodology de-
scribed for the first time by Celermajer et al. [7]
is based on evoking brachial artery ischemia and
evaluating subsequent artery dilatation due to post-
ischemic flow increase. Artery dilatation depends
on the increase of shear stress, caused by blood
pressure and blood flow velocity increase. Shear
stress is defined as a force acting on the vascular
wall area unit. As a response for the shear stress,
endothelial nitric oxide is released and vascular
smooth muscles are relaxed [8, 9]. Decreased FMD
represents endothelial dysfunction, and can be ob-
served in subjects with coronary artery risk factors
and with symptomatic CAD [10–17].
Kirma et al. [18] investigated the relationship
between FMD and CAD risk factors in 150 patients
with stable angina, evaluating the following risk fac-
tors: age, diabetes, positive family history, smok-
ing, hypertension, BMI and concentrations of total
cholesterol, HDL-cholesterol, LDL-cholesterol and
triglycerides. In univariate analysis, FMD correlat-
ed negatively with age and BMI, and in patients with
diabetes significantly lower FMD was observed. In
stepwise multivariate analysis, estimating which
risk factors have significant influence on endothe-
lial function, this relationship was confirmed with
regard to diabetes and age, but not to BMI. No cor-
relation was shown between FMD and hypercho-
lesterolemia, positive family history, hypertension
or smoking [18].
In our study, the analysis of CAD prevalence
determinants confirmed the results of Kirma et al.
[18] concerning the influence of age and diabetes
on FMD value. However, it has to be underlined that
their study group was significantly older (57.0 ±
± 11.1 years) than ours. It has already been proved
that FMD decreases as age increases [19]. Therefore,
our findings concerning the evaluation of FMD in
those below 45 years of age is even more significant.
One of our findings was that positive family
history of early CAD onset has significant influ-
ence on FMD variability as a CAD risk factor,
which was not confirmed by Kirma et al. [18]. Ne-
vertheless, there are strong indications that posi-
tive family history is a significant risk factor of
coronary artery disease, especially for young pa-
tients. Relative risk of CAD in siblings of patients
with CAD is increased 2–12 times in comparison
to the general population [20].
However, we are the first to report, on the
basis of ROC curve analysis for CAD, that low FMD
value can (with high probability) identify subjects
with asymptomatic coronary artery disease.
Figure 2. ROC curve for coronary artery disease dia-
gnosis on the basis of flow mediated dilatation.
Figure 3. ROC curve for coronary artery disease dia-
gnosis on the basis of clinical parameters in the model
of logistic regression.
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Conclusions
The evaluation of endothelial function by the
use of FMD in the population of men below 45 years
of age with diabetes and a positive family history
can help in identifying subjects at high risk of coro-
nary artery disease.
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